These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28432713)

  • 21. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.
    Blauvelt A; Reich K; Tsai TF; Tyring S; Vanaclocha F; Kingo K; Ziv M; Pinter A; Vender R; Hugot S; You R; Milutinovic M; Thaçi D
    J Am Acad Dermatol; 2017 Jan; 76(1):60-69.e9. PubMed ID: 27663079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate.
    Philippe L; Badie J; Faller JP; Krattinger É; Deconinck E; Aubin F
    Acta Derm Venereol; 2015 Apr; 95(4):495-6. PubMed ID: 25325260
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
    Gkini MA; Bewley AP
    Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
    Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Interstitial Lung Disease and Autoimmune Thyroiditis Associated with Ustekinumab.
    Lee SG; An JH; Kim DH; Yoon MS; Lee HJ
    Acta Derm Venereol; 2019 Mar; 99(3):331-332. PubMed ID: 30426134
    [No Abstract]   [Full Text] [Related]  

  • 26. Nephrotic syndrome in relation to treatment with ustekinumab.
    Pérez Fernández M; Piteiro Bermejo AB; Peña Esparragoza JK; Blasco Martínez A; Aracil Moreno I; Mancha Ramos J; Moreno Barrio F
    Nefrologia (Engl Ed); 2019; 39(1):100-102. PubMed ID: 30107955
    [No Abstract]   [Full Text] [Related]  

  • 27. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis.
    Javadzadeh S; Gkini MA; Panos GD; Adewoyin T; Bewley A
    Clin Exp Dermatol; 2020 Aug; 45(6):802-804. PubMed ID: 32212270
    [No Abstract]   [Full Text] [Related]  

  • 28. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
    Fujita Y; Shinkuma S; Nomura T; Shimizu H
    Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
    [No Abstract]   [Full Text] [Related]  

  • 30. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract]   [Full Text] [Related]  

  • 31. Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience.
    Bardazzi F; Magnano M; Campanati A; Loconsole F; Carpentieri A; Potenza C; Bernardini N; Di Lernia V; Carrera C; Raone B; Patrizi A; Loi C
    Acta Derm Venereol; 2017 Aug; 97(8):989-990. PubMed ID: 28512671
    [No Abstract]   [Full Text] [Related]  

  • 32. Varicella zoster virus meningitis under ustekinumab because of plaque psoriasis.
    Stöllberger C; Finsterer J
    J Dermatol; 2017 Jun; 44(6):703-705. PubMed ID: 28150333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative 12-week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real-world multicenter retrospective study.
    Georgakopoulos JR; Lam K; Sandhu VK; Ighani A; Phung M; Piguet V; Yeung J
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e416-e418. PubMed ID: 32176394
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
    Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
    Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracranial hypertension syndrome in a patient with psoriasis receiving ustekinumab.
    Reyes Bueno JA; Reyes Garrido V; León A; Bustamante R
    Neurologia (Engl Ed); 2019 May; 34(4):281-282. PubMed ID: 28712842
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
    Dickson L; Menter A
    J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
    Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
    Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety of systemic therapies in the treatment of psoriasis with concomitant cirrhosis: a retrospective study.
    Blaszczak AM; Dunaway S; Ali Alikhan M; Kelly S; Levin D; Kaffenberger J
    Int J Dermatol; 2019 Nov; 58(11):e228-e229. PubMed ID: 31334835
    [No Abstract]   [Full Text] [Related]  

  • 39. A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.
    Lovero R; Losurdo G; Mastromauro M; Castellaneta NM; Mongelli A; Gentile A; Di Leo A; Principi M
    Curr Drug Saf; 2018; 13(3):221-223. PubMed ID: 30027852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies.
    Watson N; Wu K; Farr P; Reynolds NJ; Hampton PJ
    Br J Dermatol; 2019 Jan; 180(1):195-196. PubMed ID: 30101563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.